Evidence map›Paper›PMID 24011581›Full record

ReviewSeminars in nephrology2013

Epigenomics of hypertension.

Mingyu Liang, Allen W Cowley, David L Mattson, Theodore A Kotchen, Yong Liu

Abstract readReview
In one paragraph

Review in Seminars in nephrology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Fibulin 2 Deficiency Drives Epigenetic Hypertension.Hypertension (Dallas, Tex. : 1979) · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. DNA NAging · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Pre-emptive medicine for hypertension and its prospects.Hypertension research : official journal of the Japanese Society of Hypertension · 2019
    Review
  12. Article
  13. Review
  14. Epigenetic Mechanisms and Hypertension.Hypertension (Dallas, Tex. : 1979) · 2018
    Review
  15. Article
  16. MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.Journal of the American Society of Nephrology : JASN · 2018
    Article
  17. DNA Methylation and Histone Modification in Hypertension.International journal of molecular sciences · 2018
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mingyu LiangDepartment of Physiology, Medical College of Wisconsin, Milwaukee, WI. Electronic address: mliang@mcw.edu.
Allen W Cowley
David L Mattson
Theodore A Kotchen
Yong Liu

Funding

VASOPRESSIN SECRETION AND CARDIOVASCULAR FUNCTIONP01HL029587 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MATTSON, DAVID L. · 1985 to 2012
$24.1M
Research ServicesP01HL082798 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI GREENE, ANDREW S. · 2006 to 2015
$22.0M
Therapeutic Effects of mTOR Inhibition in Salt-Sensitive HypertensionP01HL116264 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MATTSON, DAVID L. · 2013 to 2021
$18.7M
MicroRNA Ribonucleoprotein ComplexesR21HL111580 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI LIANG, MINGYU · 2012 to 2013
$412k
NHLBI NIH HHS HL029587NHLBI NIH HHS HL082798NHLBI NIH HHS HL111580NHLBI NIH HHS P01 HL029587NHLBI NIH HHS P01 HL082798NHLBI NIH HHS P01 HL116264NHLBI NIH HHS R21 HL111580
6 · The paper itself

Abstract

Multiple genes and pathways are involved in the pathogenesis of hypertension. Epigenomic studies of hypertension are beginning to emerge and hold great promise of providing novel insights into the mechanisms underlying hypertension. Epigenetic marks or mediators including DNA methylation, histone modifications, and noncoding RNA can be studied at a genome or near-genome scale using epigenomic approaches. At the single gene level, several studies have identified changes in epigenetic modifications in genes expressed in the kidney that correlate with the development of hypertension. Systematic analysis and integration of epigenetic marks at the genome-wide scale, demonstration of cellular and physiological roles of specific epigenetic modifications, and investigation of inheritance are among the major challenges and opportunities for future epigenomic and epigenetic studies of hypertension.

Indexed as

EpigenomicsAnimalsHumansHypertensionKidneyblood pressureDNA methylationEpigeneticshistone modificationkidney

Identifiers

PMID24011581
PMCPMC3777799

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.